Latest From Nestle SA
A group of investors has bought Nestlé Skin Health, renamed it Galderma to capitalize on its legacy in dermatology and put M&A veteran, former Shire CEO Flemming Ornskov, at its helm.
Emerging Company Profile: This is the first human study for lead product candidate THOR-707 and for the company's Expanded Genetic Alphabet platform, starting with a recombinant IL-2 that's being tested in solid tumors.
Marketer long known for iconic Hershey's Kisses and other candy products looks to grow its nutritional market revenues with One Brands' products, complementing its Oatmega business and following its investment earlier in August in UK/Ireland maker of protein bars.
Guthy-Renker disagrees with NAD's position the firm does not have objective evidence to support its treatment can “reverse crepey-looking skin.” NAD attorneys say the nature and extent of claims "should be directly analogous to the precision and specificity of the data used to substantiate.”
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Nestle Health Science SA
- Nestle HealthCare Nutrition
- Nestle Skin Health SA
- Nestle USA Inc.
- Novartis Medical Nutrition
- Owen-Galderma Laboratories Inc.
- Summit Autonomous Inc.
- Senior Management
Mark Schneider, CEO
François-Xavier Roger, EVP, CFO
Stefan Palzer, EVP, CTO
- Contact Info
Phone: (41) 21 924 2111
avenue Nestlé 55
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.